Ayala Pharmaceuticals Analyst Ratings
BenzingaNov 17, 2023 03:11
Ladenburg Thalmann Upgrades Advaxis to Buy, Announces $4 Price Target
BenzingaMay 30, 2023 19:38
Oppenheimer Downgrades Ayala Pharmaceuticals to Perform From Outperform After News of Advaxis Merger Agreement, Price Target Is $16
MT NewswiresOct 31, 2022 20:48
No Data
No Data